Literature DB >> 23364265

The world pandemic of vitamin D deficiency could possibly be explained by cellular inflammatory response activity induced by the renin-angiotensin system.

Marcelo Ferder1, Felipe Inserra, Walter Manucha, León Ferder.   

Abstract

This review attempts to show that there may be a relationship between inflammatory processes induced by chronic overstimulation of the renin-angiotensin system (RAS) and the worldwide deficiency of vitamin D (VitD) and that both disorders are probably associated with environmental factors. Low VitD levels represent a risk factor for several apparently different diseases, such as infectious, autoimmune, neurodegenerative, and cardiovascular diseases, as well as diabetes, osteoporosis, and cancer. Moreover, VitD insufficiency seems to predispose to hypertension, metabolic syndrome, left ventricular hypertrophy, heart failure, and chronic vascular inflammation. On the other hand, inappropriate stimulation of the RAS has also been associated with the pathogenesis of hypertension, heart attack, stroke, and hypertrophy of the left ventricle and vascular smooth muscle cells. Because VitD receptors (VDRs) and RAS receptors are almost distributed in the same tissues, a possible link between VitD and the RAS is even more plausible. Furthermore, from an evolutionary point of view, both systems were developed simultaneously, actively participating in the regulation of inflammatory and immunological mechanisms. Changes in RAS activity and activation of the VDR seem to be inversely related; thus any changes in one of these systems would have a completely opposite effect on the other, making it possible to speculate that the two systems could have a feedback relationship. In fact, the pandemic of VitD deficiency could be the other face of increased RAS activity, which probably causes lower activity or lower levels of VitD. Finally, from a therapeutic point of view, the combination of RAS blockade and VDR stimulation appears to be more effective than either RAS blockade or VDR stimulation individually.

Entities:  

Keywords:  angiotensin receptor blocker; cardiovascular disease; mitochondria; oxidative stress; vitamin D receptor

Mesh:

Year:  2013        PMID: 23364265      PMCID: PMC4073895          DOI: 10.1152/ajpcell.00403.2011

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  179 in total

Review 1.  Localization and function of angiotensin AT1 receptors.

Authors:  A M Allen; J Zhuo; F A Mendelsohn
Journal:  Am J Hypertens       Date:  2000-01       Impact factor: 2.689

Review 2.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

3.  Effects of AT1 receptor antagonist, losartan, on rat hepatic fibrosis induced by CCl(4).

Authors:  Hong-Shan Wei; Ding-Guo Li; Han-Ming Lu; Yu-Tao Zhan; Zhi-Rong Wang; Xin Huang; Jing Zhang; Ji-Lin Cheng; Qin-Fang Xu
Journal:  World J Gastroenterol       Date:  2000-08       Impact factor: 5.742

4.  1,25-dihydroxyvitamin D3 stimulates transforming growth factor-beta1 synthesis by mouse renal proximal tubular cells.

Authors:  T Weinreich; M Landolt; C Booy; R Wüthrich; U Binswanger
Journal:  Kidney Blood Press Res       Date:  1999       Impact factor: 2.687

5.  Expression profiling of vitamin D receptor in placenta, decidua and ovary of pregnant mice.

Authors:  M Shahbazi; M Jeddi-Tehrani; M Zareie; A Salek-Moghaddam; M M Akhondi; M Bahmanpoor; M R Sadeghi; A H Zarnani
Journal:  Placenta       Date:  2011-07-18       Impact factor: 3.481

Review 6.  Vitamin D, blood pressure, and African Americans: toward a unifying hypothesis.

Authors:  Stephen G Rostand
Journal:  Clin J Am Soc Nephrol       Date:  2010-07-22       Impact factor: 8.237

Review 7.  Vitamin D and diabetes.

Authors:  Tatiana Takiishi; Conny Gysemans; Roger Bouillon; Chantal Mathieu
Journal:  Endocrinol Metab Clin North Am       Date:  2010-06       Impact factor: 4.741

8.  Differential inhibition of renin mRNA expression by paricalcitol and calcitriol in C57/BL6 mice.

Authors:  Ryan M Fryer; Pamela A Rakestraw; Masaki Nakane; Doug Dixon; Patricia N Banfor; Kristin A Koch; J Ruth Wu-Wong; Glenn A Reinhart
Journal:  Nephron Physiol       Date:  2007-07-02

9.  1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter.

Authors:  Weihua Yuan; Wei Pan; Juan Kong; Wei Zheng; Frances L Szeto; Kari E Wong; Ronald Cohen; Anna Klopot; Zhongyi Zhang; Yan Chun Li
Journal:  J Biol Chem       Date:  2007-08-09       Impact factor: 5.157

10.  Mitochondrial localization of vitamin D receptor in human platelets and differentiated megakaryocytes.

Authors:  Francesca Silvagno; Enrico De Vivo; Angelo Attanasio; Valentina Gallo; Gianna Mazzucco; Gianpiero Pescarmona
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

View more
  35 in total

1.  Renoprotective effects of vitamin D3 supplementation in a rat model of metabolic syndrome.

Authors:  Nehal S Wahba; Salah A Ghareib; Rasha H Abdel-Ghany; Mohamed Abdel-Aal; Amira E Alsemeh
Journal:  Eur J Nutr       Date:  2020-04-22       Impact factor: 5.614

Review 2.  Emerging Role of Nitric Oxide and Heat Shock Proteins in Insulin Resistance.

Authors:  Marisa Nile Molina; León Ferder; Walter Manucha
Journal:  Curr Hypertens Rep       Date:  2016-01       Impact factor: 5.369

Review 3.  Hypertension and insulin resistance: implications of mitochondrial dysfunction.

Authors:  Walter Manucha; Bob Ritchie; León Ferder
Journal:  Curr Hypertens Rep       Date:  2015-01       Impact factor: 5.369

4.  Relationship Between Vitamin D Deficiency and the Components of Metabolic Syndrome in Patients with Morbid Obesity, Before and 1 Year After Laparoscopic Roux-en-Y Gastric Bypass or Sleeve Gastrectomy.

Authors:  Ana Obispo Entrenas; David Legupin Tubio; Fabiola Lucena Navarro; Francisco Martin Carvajal; Norberto Gandara Adan; Maximino Redondo Bautista; Jimena Abiles Osinaga
Journal:  Obes Surg       Date:  2017-05       Impact factor: 4.129

Review 5.  The protective role of vitamin D on the heart and the kidney.

Authors:  Walter Manucha; Luis I Juncos
Journal:  Ther Adv Cardiovasc Dis       Date:  2016-10-26

Review 6.  Inflammation, oxidative stress and renin angiotensin system in atherosclerosis.

Authors:  Kazim Husain; Wilfredo Hernandez; Rais A Ansari; Leon Ferder
Journal:  World J Biol Chem       Date:  2015-08-26

7.  Effect of paricalcitol and enalapril on renal inflammation/oxidative stress in atherosclerosis.

Authors:  Kazim Husain; Edu Suarez; Angel Isidro; Wilfredo Hernandez; Leon Ferder
Journal:  World J Biol Chem       Date:  2015-08-26

Review 8.  Potential pathophysiological role for the vitamin D deficiency in essential hypertension.

Authors:  Federico Carbone; François Mach; Nicolas Vuilleumier; Fabrizio Montecucco
Journal:  World J Cardiol       Date:  2014-05-26

9.  Vitamin D receptor-modulated Hsp70/AT1 expression may protect the kidneys of SHRs at the structural and functional levels.

Authors:  Isabel Mercedes García; Liliana Altamirano; Luciana Mazzei; Miguel Fornés; Fernando Darío Cuello-Carrión; León Ferder; Walter Manucha
Journal:  Cell Stress Chaperones       Date:  2013-11-13       Impact factor: 3.667

Review 10.  Anti-Inflammatory Effects of Melatonin in Obesity and Hypertension.

Authors:  Natalia Jorgelina Prado; León Ferder; Walter Manucha; Emiliano Raúl Diez
Journal:  Curr Hypertens Rep       Date:  2018-05-09       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.